Most men should get their first prostate screening between ages 45 and 50. That’s the window when the American Urological Association recommends a baseline PSA blood test for men at average risk. But if you’re Black or have a family history of prostate cancer, the timeline moves earlier, starting as young as 40.
The right age depends on your personal risk profile, and the screening itself has changed significantly in recent years. Here’s what you need to know to make a good decision.
Starting Ages by Risk Level
There’s no single answer because prostate cancer doesn’t affect all men equally. Guidelines break it down into three groups:
- Average risk: Begin screening between ages 45 and 50. The large clinical trials that proved screening saves lives enrolled men starting at 50 and 55, so there’s strong evidence supporting this range.
- Higher risk (family history): If your father or brother was diagnosed with prostate cancer before age 65, the American Cancer Society recommends starting the conversation at 45. If more than one close relative had prostate cancer at a young age, start at 40.
- Highest risk (Black men or BRCA carriers): Black men in the U.S. face the highest rates of prostate cancer diagnosis and death of any group. Modeling studies show prostate cancer develops 3 to 9 years earlier in Black men compared to non-Black men. The Prostate Cancer Foundation recommends baseline testing between ages 40 and 45. Men with BRCA2 gene mutations should also begin at 40.
What “Prostate Exam” Actually Means Now
When most people think of a prostate exam, they picture a digital rectal exam. That physical exam still exists, but the primary screening tool today is a PSA blood test. PSA (prostate-specific antigen) is a protein produced by the prostate, and elevated levels can signal cancer, though they can also reflect non-cancerous conditions like an enlarged prostate or an infection.
The test itself is just a standard blood draw. No preparation is dramatic, but there are two things to avoid in the 48 hours beforehand: sexual activity (including masturbation) and vigorous exercise, especially cycling. Both can temporarily raise PSA levels and give you a falsely elevated reading.
What Your PSA Number Means
Your result comes back as a number measured in nanograms per milliliter. What counts as “normal” shifts with age. According to Johns Hopkins Medicine, for men in their 40s and 50s, a PSA above 2.5 is considered abnormal, while the typical reading for that age range is only 0.6 to 0.7. For men in their 60s, the threshold rises to 4.0, with a normal range between 1.0 and 1.5.
A high PSA does not mean you have cancer. In the large U.S. screening trial, more than two-thirds of men who had a biopsy because of an elevated PSA turned out not to have prostate cancer at all. That’s why your baseline number matters so much. It gives your doctor a reference point to track changes over time rather than relying on a single snapshot.
How Often to Rescreen
Your first PSA result determines how frequently you need to come back. The intervals vary quite a bit based on that initial number.
For men aged 40 to 60: if your PSA is below 1.0, you’re at very low risk of a prostate cancer diagnosis in the next five years, so retesting every five years or longer is reasonable. If your PSA falls between 1.0 and 2.0, the interval tightens to every six to twelve months.
For men aged 61 to 75: a PSA below 1.0 still warrants retesting only every five years. Between 1.0 and 3.0, you’d recheck every six to twelve months. For Black men who choose screening, annual testing is strongly recommended regardless of PSA level, given the faster progression patterns seen in this population.
When to Stop Screening
Prostate cancer typically grows slowly, and the benefit of catching it early diminishes when a man’s remaining life expectancy is limited by age or other health conditions. The major clinical trials showing screening benefits focused on men up to age 69. Most guidelines suggest that men over 70 to 75, or those with fewer than 10 to 15 years of life expectancy, can reasonably stop routine screening. At that point the risks of overdiagnosis and unnecessary treatment tend to outweigh the potential gains.
The Trade-Offs of Screening
Prostate screening saves lives, but the numbers are more modest than many men expect. Based on data from the largest European screening trial, here’s what happens when 1,000 men aged 55 to 69 are invited to undergo PSA screening over 13 years: about 240 will get at least one elevated result, roughly 220 will undergo a biopsy, 100 will be diagnosed with prostate cancer, and 1.3 will avoid dying from the disease because it was caught through screening.
The U.S. Preventive Services Task Force estimates that 20% to 50% of men diagnosed through screening are “overdiagnosed,” meaning their cancer would never have caused symptoms or death in their lifetime. Treatment for prostate cancer carries real risks, including incontinence and erectile dysfunction, so being diagnosed with a cancer that didn’t need treating can cause significant harm.
This is exactly why guidelines now emphasize shared decision-making rather than blanket recommendations. A low baseline PSA in your mid-40s can be deeply reassuring and may spare you years of unnecessary worry. A high-risk profile, on the other hand, makes early and regular screening a genuinely life-saving choice. The key is knowing which group you fall into so you and your doctor can choose the right approach for your situation.